Dihydroergotamine mesylate (Amneal)

N/A

Report date: 2025/05/30 10:43:14

Base Information

Drug NameDihydroergotamine mesylate (Amneal)
Drug Alias NameBrekiya
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1b (5-HT1b) receptor agonistsSerotonin 1d (5-HT1d) receptor agonists
TargetsSerotonin 1b (5-HT1b) receptorSerotonin 1d (5-HT1d) receptor
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsMigraine Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/05/14
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAmneal Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmneal Pharmaceuticals IncAmneal Pharmaceuticals Llc
Inactive CompaniesN/A
Active IndicationsMigraine Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A